Summary of AVI BIOPHARMA INC

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

SRPT > SEC Filings for SRPT > Form 8-K on 2-Apr-2012

All Recent SEC Filings

Show all filings for AVI BIOPHARMA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for AVI BIOPHARMA INC

2-Apr-2012

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On April 2, 2012, AVI BioPharma, Inc. issued a press release announcing top-line results from its Phase IIb study evaluating eteplirsen for the treatment of Duchenne muscular dystrophy. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

                   Exhibit
                   Number    Description

                   99.1      Press release dated April 2, 2012.

Add SRPT to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for SRPT - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.